HDCTX
Price
$9.53
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
JHQPX
Price
$33.13
Change
+$0.02 (+0.06%)
Updated
Oct 17 closing price
Ad is loading...

HDCTX vs JHQPX

Header iconHDCTX vs JHQPX Comparison
Open Charts HDCTX vs JHQPXBanner chart's image
Rational Equity Armor Fund Instl
Price$9.53
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JPMorgan Hedged Equity R5
Price$33.13
Change+$0.02 (+0.06%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HDCTX vs JHQPX Comparison Chart
Loading...
VS
HDCTX vs. JHQPX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HDCTX is a Buy and JHQPX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JHQPX has more cash in the bank: 20.8B vs. HDCTX (35.7M). JHQPX pays higher dividends than HDCTX: JHQPX (1.03) vs HDCTX (0.03). HDCTX was incepted earlier than JHQPX: HDCTX (24 years) vs JHQPX (11 years). HDCTX is a more actively managed with annual turnover of: 580.00 vs. JHQPX (27.00). JHQPX has a lower initial minimum investment than HDCTX: JHQPX (0) vs HDCTX (1000). HDCTX annual gain was more profitable for investors over the last year : 24.58 vs. JHQPX (22.91). JHQPX return over 5 years is better than : 68.23 vs. HDCTX (47.95).
HDCTXJHQPXHDCTX / JHQPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years11 years-
Gain YTD16.36117.82892%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets35.7M20.8B0%
Annual Yield % from dividends0.031.033%
Returns for 1 year24.5822.91107%
Returns for 3 years11.0027.9739%
Returns for 5 years47.9568.2370%
Returns for 10 years13.56132.1510%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRFOX33.120.21
+0.64%
Marshfield Concentrated Opportunity
LMUSX24.730.13
+0.53%
Franklin U.S. Large Cap Equity FI
PAMCX104.870.45
+0.43%
T. Rowe Price Mid-Cap Growth Adv
SBHSX12.080.03
+0.25%
Segall Bryant & Hamill Intl Sm Cp Ret
GEMUX24.90N/A
N/A
Goldman Sachs Emerging Markets Eq R6